VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA

Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02740-16. doi: 10.1128/AAC.02740-16. Print 2017 May.

Abstract

Acquisition of vancomycin resistance in Staphylococcus aureus is often accompanied by a reduction in virulence, but the mechanisms underlying this change remain unclear. The present study was undertaken to investigate this process in a clinical heterogeneous vancomycin-intermediate S. aureus (hVISA) strain, 10827; an hVISA reference strain, Mu3; and a VISA reference strain, Mu50, along with their respective series of vancomycin-induced resistant strains. In these strains, increasing MICs of vancomycin were associated with increased expression of the vancomycin resistance-associated regulator gene (vraR) and decreased expression of virulence genes (hla, hlb, and coa) and virulence-regulated genes (RNAIII, agrA, and saeR). These results suggested that VraR might have a direct or indirect effect on virulence in S. aureus In electrophoretic mobility shift assays, VraR did not bind to promoter sequences of hla, hlb, and coa genes, but it did bind to the agr promoter region. In DNase I footprinting assays, VraR protected a 15-nucleotide (nt) sequence in the intergenic region between the agr P2 and P3 promoters. These results indicated that when S. aureus is subject to induction by vancomycin, expression of vraR is upregulated, and VraR binding inhibits the function of the Agr quorum-sensing system, causing reductions in the virulence of VISA/hVISA strains. Our results suggested that VraR in S. aureus is involved not only in the regulation of vancomycin resistance but also in the regulation of virulence.

Keywords: Staphylococcus aureus; global regulatory networks; two-component regulatory systems; vancomycin resistance; virulence regulation.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / biosynthesis
  • Bacterial Proteins / genetics*
  • Bacterial Proteins / metabolism*
  • Bacterial Toxins / biosynthesis
  • DNA-Binding Proteins / metabolism*
  • Hemolysin Proteins / biosynthesis
  • Microbial Sensitivity Tests
  • Porins / biosynthesis
  • Promoter Regions, Genetic / genetics*
  • Quorum Sensing / drug effects
  • RNA, Bacterial / biosynthesis
  • Sphingomyelin Phosphodiesterase / biosynthesis
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / pathology
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / genetics*
  • Staphylococcus aureus / pathogenicity
  • Trans-Activators / genetics*
  • Transcription Factors / biosynthesis
  • Vancomycin / pharmacology*
  • Vancomycin Resistance / genetics*
  • Virulence / drug effects
  • Virulence Factors / biosynthesis

Substances

  • Agr protein, Staphylococcus aureus
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Bacterial Toxins
  • DNA-Binding Proteins
  • Hemolysin Proteins
  • OmpF protein
  • Porins
  • RNA, Bacterial
  • RNAIII, Staphylococcus aureus
  • SaeR protein, Staphylococcus aureus
  • Trans-Activators
  • Transcription Factors
  • Virulence Factors
  • VraR protein, Staphylococcus aureus
  • VraS protein, Staphylococcus aureus
  • staphylococcal alpha-toxin
  • Vancomycin
  • Sphingomyelin Phosphodiesterase
  • hlb protein, Staphylococcus aureus